为评估移动健康患者参与技术（PET）对妇科肿瘤学病人术后结果的影响。从2019年7月至2021年5月，对所有进行腹腔镜手术的妇科肿瘤学病人进行了强化恢复计划（ERP）的接触，以便加入PET，该平台可以通过计算机、平板电脑或智能手机访问。该平台提供增强的术前和术后患者教育和远程患者监测。选择参与的患者根据年龄和共病症接受针对性的教育，并被要求在术后期间完成每日健康检查。将PET组的参与者与选择退出的患者以及PET实施之前的历史队列进行比较。记录患者和手术水平的因素。主要结果为住院时间（LOS）和30天再入院率。使用SPSS v.26进行分析。682名妇科肿瘤学病人在研究期间符合纳入标准；PET组347名和对照组335名。PET组和对照组在人口统计学和其他因素（包括种族、BMI（kg/m2）、Charlson共病症指数（CCI）、手术复杂性和保险状况）方面没有差异；然而，PET组患者年龄稍小（55.0岁 vs. 57.2岁；p = 0.04）。与对照组相比，PET组患者住院时间显著缩短（2.9天 vs. 3.6天；p < 0.01），再入院率较低（4.3% vs. 8.6%；p < 0.01）。我们妇科肿瘤学病人使用PET几乎减少了一天的住院时间，尽管在年龄以外的其他人口统计学和手术因素方面没有差异。此外，PET组再入院率降低了50%。使用PET可以让医疗专业人员以改善围手术期护理的方式与患者进行参与、评估和治疗。版权所有 © 2023 Elsevier Inc. 保留所有权利。

To evaluate the impact of a mobile health patient engagement technology (PET) on postoperative outcomes in gynecologic oncology patients.All gynecologic oncology patients undergoing laparotomy on an enhanced recovery program (ERP) were approached from July 2019 to May 2021 to enroll in a PET, which can be accessed by computer, tablet, or smart phone. This platform provides enhanced pre- and postoperative patient education and remote patient monitoring. Patients who elected to participate were provided with targeted education based on their age and comorbidities and were asked to complete daily health checks during the postoperative period. Participants in the PET were compared to patients who opted out as well as to a historical cohort from prior to PET implementation. Patient and procedure-level factors were recorded. The primary outcomes were length of stay (LOS) and 30-day readmission rate. Analysis was performed using SPSS v.26.682 women met inclusion criteria during the study time; 347 in the PET group and 335 in the control group. Demographic and other factors including race, BMI (kg/m2), Charlson Comorbidity Index (CCI), surgical complexity, and insurance status were not different between the PET and control group; however, patients in the PET cohort were slightly younger (55.0 yo vs. 57.2 yo; p = 0.04). Patients in the PET group had a significantly shorter LOS (2.9 days vs. 3.6 days; p < 0.01) and lower readmission rate (4.3% vs. 8.6%; p < 0.01) when compared with the control group.Use of a PET in our gynecologic oncology patients decreased LOS by nearly one day despite an absence of differences in other demographic and surgical factors other than age. Furthermore, there was a 50% reduction in readmission rates in the PET group. The use of a PET allows for healthcare professionals to engage, evaluate, and treat patients in a way that improves perioperative care.Copyright © 2023 Elsevier Inc. All rights reserved.